Test Description

What is ALT?

Alanine aminotransferase (ALT), also known as serum glutamic-pyruvic transaminase (SGPT), is an enzyme predominantly found in hepatocytes (liver cells). It catalyzes the transfer of an amino group from L-alanine to alpha-ketoglutarate, playing a crucial role in amino acid metabolism and the citric acid cycle.

Why is ALT Special?

ALT is considered the most specific marker for hepatocellular injury because:

  • Highest concentration: Found primarily in the liver
  • Minimal elsewhere: Only small amounts in kidneys, heart, and skeletal muscle
  • Sensitive release: When hepatocytes are damaged or destroyed, ALT is released into the bloodstream
  • Excellent screening: Makes ALT the best tool for detecting liver disease

How is the Test Performed?

  • Sample type: Serum or plasma via standard venipuncture
  • Preparation: No special preparation required (some labs recommend fasting)
  • Typically ordered as part of: Comprehensive metabolic panel (CMP) or hepatic function panel

Clinical Utility

  • Screening: Detection of asymptomatic liver disease in at-risk populations
  • Diagnosis: Differentiating hepatocellular from cholestatic liver injury
  • Monitoring: Tracking disease progression or treatment response in chronic liver disease
  • Medication safety: Monitoring for drug-induced liver injury (DILI) with hepatotoxic medications
Quick Reference
  • Normal Range: 7-35 IU/L
  • Males (typical): 7-40 IU/L
  • Females (typical): 7-35 IU/L
  • Also Known As: SGPT (Serum Glutamic-Pyruvic Transaminase)
  • Sample Type: Serum or plasma
  • Key Point: Most specific marker for hepatocellular injury
Normal Ranges

Normal ALT values vary slightly by laboratory, assay methodology, age, sex, and body mass index. The ranges below represent typical values, but always compare results to your specific laboratory's reference range.

Swipe to see more
Population Normal Range Notes
Adult Males 7-40 IU/L Upper limit may vary 29-55 IU/L by lab
Adult Females 7-35 IU/L Generally 10-25% lower than males
Children 10-40 IU/L Age-dependent; higher in adolescents
Elderly (>65 years) Similar to adults May be slightly lower in frail elderly

Important Considerations

ALT reference ranges have significant limitations that clinicians should be aware of:

  • Assay variation: Different laboratory platforms may report significantly different reference ranges (as wide as 10-55 IU/L)
  • Gender differences: Males typically have 10-30% higher ALT values than females, likely due to differences in muscle mass and hormonal influences
  • BMI influence: Obese individuals may have elevated ALT due to non-alcoholic fatty liver disease (NAFLD), even within the "normal" range
  • Ethnicity: Some ethnic groups (particularly Asian populations) may have different baseline ALT levels
  • Subclinical disease: Values in the "high-normal" range (e.g., 30-40 IU/L) may indicate early liver disease, particularly in the setting of metabolic syndrome
Clinical Significance

Elevated ALT

Elevated ALT indicates hepatocellular injury or death. The magnitude of elevation helps narrow the differential diagnosis and suggests the underlying pathophysiology:

Mild Elevation (1-2x Upper Limit Normal, <100 IU/L)

  • Non-alcoholic fatty liver disease (NAFLD/NASH): Most common cause of chronic mild ALT elevation in developed countries
  • Chronic viral hepatitis: Hepatitis B or C with low-level chronic inflammation
  • Alcoholic liver disease: Early stages, though AST typically predominates
  • Medication-related: Statins, methotrexate, anticonvulsants, isoniazid
  • Hemochromatosis: Iron overload causing gradual hepatocyte damage
  • Autoimmune hepatitis: May present with mild elevation, especially in early stages
  • Celiac disease: Associated with mild transaminitis in some patients

Moderate Elevation (2-5x ULN, 100-250 IU/L)

  • Acute viral hepatitis: Hepatitis A, B, C, E, EBV, CMV
  • Drug-induced liver injury (DILI): Acetaminophen (subacute), antibiotics, NSAIDs
  • Alcoholic hepatitis: Though AST/ALT ratio typically >2:1
  • Autoimmune hepatitis: Active inflammation
  • Chronic liver diseases: More active NASH, chronic hepatitis with flares

Severe Elevation (5-10x ULN, 250-500 IU/L)

  • Acute viral hepatitis: Peak inflammation phase
  • Autoimmune hepatitis: Severe exacerbation
  • Drug-induced liver injury: Acute hepatotoxic reactions
  • Ischemic hepatitis: "Shock liver" from hypoperfusion
  • Acute bile duct obstruction: May cause initial transaminitis before ALP rise

Massive Elevation (>10x ULN, >500 IU/L)

  • Acute viral hepatitis: Hepatitis A, B, E most common
  • Acetaminophen toxicity: Classic cause of massive ALT elevation (often >1000 IU/L, can exceed 10,000 IU/L)
  • Ischemic hepatitis: Shock, severe hypotension, cardiac arrest
  • Acute Budd-Chiari syndrome: Hepatic vein thrombosis
  • Acute autoimmune hepatitis: Severe presentation
  • Toxin-induced: Amanita mushroom poisoning, carbon tetrachloride
  • HELLP syndrome: In pregnancy (Hemolysis, Elevated Liver enzymes, Low Platelets)
  • Acute Wilson disease: Rare but critical to identify

Critical Values Requiring Urgent Evaluation

ALT >1000 IU/L requires immediate investigation:

  1. Assess for acute liver failure: Check INR/PT, bilirubin, mental status, and albumin
  2. Rule out acetaminophen toxicity: Obtain acetaminophen level regardless of history (intentional or unintentional overdose)
  3. Consider ischemic hepatitis: Review hemodynamic status, cardiac function, recent hypotensive episodes
  4. Hepatology consultation: Consider for ALT >500 IU/L with coagulopathy or rising bilirubin
  5. Admit for monitoring: Most patients with massive transaminitis require inpatient care

Decreased ALT

Low or undetectable ALT is uncommon and rarely clinically significant. When present, it may indicate:

Causes of Low ALT

  • Vitamin B6 deficiency: ALT requires pyridoxal phosphate as a cofactor; severe deficiency can reduce ALT levels
  • End-stage liver disease: Cirrhosis with few remaining viable hepatocytes may paradoxically normalize ALT despite severe disease
  • Chronic kidney disease: Reduced ALT synthesis or increased clearance
  • Normal variant: Some healthy individuals have very low baseline ALT

Important: A normal or low ALT does not exclude significant liver disease, especially cirrhosis or chronic hepatitis. In advanced cirrhosis, ALT may normalize despite ongoing liver dysfunction.

Interpretation Guidelines

ALT:AST Ratio

The ratio of ALT to AST provides important diagnostic clues about the etiology of liver disease:

Swipe to see more
ALT:AST Ratio Interpretation Common Causes
>1 (ALT > AST) Typical for most liver diseases Viral hepatitis, NAFLD/NASH, drug-induced liver injury, autoimmune hepatitis
>2:1 (ALT >> AST) Highly suggestive of specific etiologies Acute viral hepatitis, NAFLD, drug-induced hepatitis
<1 (AST > ALT) Suggests alcoholic liver disease or cirrhosis Chronic alcohol use, advanced cirrhosis (any cause)
>2:1 (AST >> ALT) Classic for alcoholic hepatitis Alcoholic hepatitis, advanced cirrhosis, Wilson disease
>3:1 with AST <300 Strongly suggests alcohol Chronic alcoholic liver disease
AST:ALT Ratio (De Ritis Ratio)
AST:ALT Ratio = AST (IU/L) / ALT (IU/L)

Interpretation: Ratio <1 is typical for most liver diseases. Ratio >2 suggests alcoholic liver disease or cirrhosis. In alcoholic hepatitis, AST is typically >2 times ALT, but both are usually <300 IU/L (contrasts with viral hepatitis where both may be >1000 IU/L).

Pattern Recognition: Hepatocellular vs Cholestatic

The pattern of liver enzyme elevation helps distinguish hepatocellular injury from cholestatic or infiltrative processes:

Swipe to see more
Pattern ALT/AST Alkaline Phosphatase R Value*
Hepatocellular Elevated (prominent) Normal or mildly elevated R ≥5
Cholestatic Normal or mildly elevated Elevated (prominent) R ≤2
Mixed Elevated Elevated R = 2-5

*R Value: (ALT ÷ ALT Upper Limit Normal) / (ALP ÷ ALP Upper Limit Normal). This ratio helps classify the pattern of liver injury.

Serial Measurements

Timing and Interpretation of Follow-up Testing

  • Acute hepatitis: ALT peaks within 1-2 weeks, normalizes over 4-12 weeks in uncomplicated cases
  • Acetaminophen toxicity: ALT peaks 24-72 hours post-ingestion, may reach >10,000 IU/L
  • Ischemic hepatitis: Rapid rise and fall; ALT peaks 1-3 days after insult, then rapidly decreases
  • Chronic liver disease: Persistently elevated for >6 months; fluctuations suggest ongoing injury
  • Drug-induced liver injury: Variable pattern; should improve within weeks of stopping offending agent
  • NAFLD/NASH: Persistently elevated, often fluctuating; may normalize with weight loss/lifestyle changes

When ALT Normalization is Concerning

Paradoxically, a falling or normalizing ALT can sometimes indicate worsening liver function:

  • Acute liver failure: Falling ALT with rising INR/PT and bilirubin suggests massive hepatocyte loss
  • End-stage cirrhosis: ALT normalizes as fewer hepatocytes remain to release enzyme
  • Fulminant hepatitis: Rapid decrease in very high ALT with deteriorating synthetic function is ominous

Always interpret ALT in context with other liver function tests (albumin, INR, bilirubin) and clinical status.

Interfering Factors

Medications That Increase ALT

  • Acetaminophen: Dose-dependent hepatotoxicity; therapeutic doses generally safe, but >4g/day or chronic use increases risk
  • Statins: Mild elevation in 1-3% of patients; usually transient and clinically insignificant
  • Antibiotics: Amoxicillin-clavulanate, nitrofurantoin, sulfonamides, isoniazid, rifampin
  • Anticonvulsants: Phenytoin, valproic acid, carbamazepine
  • NSAIDs: Particularly diclofenac; risk increases with chronic use
  • Antifungals: Ketoconazole, fluconazole, itraconazole (especially with prolonged therapy)
  • Antiretrovirals: Many HIV medications can cause hepatotoxicity
  • Herbals/supplements: Kava, green tea extract, anabolic steroids, many others
  • Immunosuppressants: Methotrexate, azathioprine
  • Cardiovascular drugs: Amiodarone, hydralazine

Pre-analytical Factors Affecting Results

  • Hemolysis: Can falsely elevate ALT due to release from red blood cells (though effect is less than with AST)
  • Strenuous exercise: Vigorous activity within 24 hours can mildly elevate ALT from muscle injury
  • Specimen storage: ALT is relatively stable at room temperature for 24 hours; refrigeration preferred for longer storage
  • Lipemia: Severe hypertriglyceridemia may interfere with some assay methods

Physiologic Factors

  • Body mass index (BMI): Obesity increases ALT due to NAFLD prevalence
  • Gender: Males have 10-30% higher baseline ALT than females
  • Age: Slight increase with age, though elderly may have lower values
  • Ethnicity: Some variation exists across different ethnic groups
  • Muscle mass: Higher muscle mass associated with slightly higher ALT
  • Pregnancy: Normally unchanged; elevation suggests pregnancy-specific liver disease (HELLP, acute fatty liver)

Conditions Causing Falsely Normal or Low ALT

  • Vitamin B6 (pyridoxine) deficiency: Required as cofactor for ALT; severe deficiency lowers measured ALT
  • Chronic kidney disease: May have lower ALT levels
  • Advanced cirrhosis: Normalized ALT despite ongoing liver dysfunction due to reduced hepatocyte mass

Extrahepatic Sources of ALT

While ALT is considered liver-specific, it is also present in smaller amounts in:

  • Skeletal muscle: Severe rhabdomyolysis can mildly elevate ALT (though CK elevation is much more prominent)
  • Kidney: Renal disease rarely causes isolated ALT elevation
  • Heart: Myocardial infarction typically causes minimal ALT elevation compared to AST

Clinical Pearl: If extrahepatic sources are suspected, check CK (for muscle), troponin (for heart), and consider imaging or additional testing. True isolated ALT elevation is almost always hepatic in origin.

Clinical Pearls
  • "ALT is the Alanine Liver Test": ALT is more specific for liver injury than AST, which is also elevated in cardiac and muscle disease. When both are elevated, consider the source; when only ALT is elevated, think liver first.
  • The "2:1 Rule" for alcohol: In alcoholic hepatitis, AST is typically more than twice ALT, and both are usually <300 IU/L. If you see AST:ALT ratio >2:1 with both values <300, alcohol should be your top differential. Remember: "AST is Above with Sauce (alcohol)."
  • Don't miss acetaminophen toxicity: Any patient with massive transaminitis (ALT >1000 IU/L) needs an acetaminophen level checked immediately, even with no reported ingestion. Many cases are unintentional overdoses from combination products or therapeutic misadventure.
  • "Normal ALT doesn't mean normal liver": Patients with cirrhosis often have normal or near-normal transaminases because there are few hepatocytes left to die. Always assess synthetic function (albumin, INR) and imaging to evaluate for chronic liver disease, not just ALT.
  • The magnitude matters more than you think: ALT >1000 IU/L has a very limited differential: acute viral hepatitis, ischemic hepatitis, acetaminophen toxicity, autoimmune hepatitis, Budd-Chiari, or toxins. Chronic liver diseases (NAFLD, chronic hepatitis) rarely cause such dramatic elevations.
  • Beware the falling ALT with rising bilirubin: In acute liver failure, a rapidly declining ALT combined with worsening coagulopathy (rising INR) and rising bilirubin is a sign of massive hepatocyte necrosis and impending liver failure—not improvement.
  • NAFLD is now the most common cause: In Western countries, non-alcoholic fatty liver disease is the leading cause of chronic ALT elevation. Screen patients with metabolic syndrome, obesity, or diabetes for NAFLD if ALT is persistently elevated.
  • Ischemic hepatitis is "the forgotten cause": In ICU or ED patients with massive transaminitis (often >1000 IU/L) and recent hypotension, cardiac arrest, or shock, consider ischemic hepatitis ("shock liver"). LDH is also markedly elevated. ALT rises rapidly and falls rapidly once perfusion is restored.
  • When to repeat testing: Isolated mild ALT elevation (1-2x ULN) should be repeated in 2-4 weeks to confirm it's not transient. Persistently elevated ALT (>6 months) requires further workup. Acute severe elevation requires immediate investigation.
  • Check for hemolysis before panicking: If ALT seems disproportionately high or the specimen looks pink/red, hemolyzed samples can cause falsely elevated results. Request a repeat non-hemolyzed sample before extensive workup.
  • Compare to ALP to determine the pattern: Calculate the R value: (ALT/ALT_ULN) / (ALP/ALP_ULN). R ≥5 = hepatocellular, R ≤2 = cholestatic, R 2-5 = mixed. This pattern directs your diagnostic approach and imaging choices.
  • Don't forget non-hepatic causes in the right context: Celiac disease, thyroid disease, and muscle disorders can all cause mild ALT elevation. If liver workup is negative and ALT is <100, consider these diagnoses.
  • "Statins rarely require discontinuation": Mild ALT elevation (<3x ULN) with statins is common and usually benign. Current guidelines recommend continuing statins and monitoring unless ALT >3x ULN persists. The cardiovascular benefit usually outweighs mild transaminitis.
  • Viral hepatitis time course: In acute viral hepatitis A or B, ALT typically peaks at 1-2 weeks and normalizes by 3-4 months. Persistently elevated ALT beyond 6 months suggests chronic hepatitis (only possible with HBV and HCV, not HAV).
  • Think zebras when nothing else fits: If workup for common causes is negative and ALT remains elevated, consider Wilson disease (especially age <40), alpha-1 antitrypsin deficiency, hemochromatosis, or autoimmune hepatitis. These are rare but treatable.
References
  1. Kratz, A., Ferraro, M., Sluss, P. M., & Lewandrowski, K. B. (2004). Laboratory reference values. New England Journal of Medicine, 351, 1548-1564.
  2. Lee, M. (Ed.). (2009). Basic skills in interpreting laboratory data. Ashp.
  3. Farinde, A. (2021). Lab values, normal adult: Laboratory reference ranges in healthy adults. Medscape. https://emedicine.medscape.com/article/2172316-overview?form=fpf
  4. Nickson, C. (n.d.). Critical Care Compendium. Life in the Fast Lane • LITFL. https://litfl.com/ccc-critical-care-compendium/
  5. Farkas, Josh MD. (2015). Table of Contents - EMCrit Project. EMCrit Project. https://emcrit.org/ibcc/toc/
Back to Liver Panel All Lab Values
Medical Disclaimer
  • For Educational Purposes Only: This content is intended for educational reference and should not be used for clinical decision-making.
  • Not a Substitute for Professional Judgment: Always consult your local protocols, institutional guidelines, and supervising physicians.
  • Verify Before Acting: Users are responsible for verifying information through authoritative sources before any clinical application.
AI Assistance Notice
The clinical content and references are curated and reviewed by myself; however, AI was used to assist in organizing, paraphrasing, and formatting the information presented.